Literature DB >> 6157684

Mechanisms of action of human interferons. Induction of 2'5'-oligo(A) polymerase.

C Baglioni, P A Maroney.   

Abstract

Interferons induce an enzymatic activity that polymerizes ATP into 2'5'-oligoadenylate. This enzyme, designated 2'5'-oligo(A) polymerase, is induced in HeLa cells by type I interferon with a faster kinetics than by type II (immune) interferon. Cells treated with type I interferon in the presence of cycloheximide show elevated levels of polymerase when the inhibitor or protein synthesis is removed and actinomycin D is added to the cultures to prevent further synthesis of mRNA. This suggests that, in the presence of cycloheximide, interferon can activate transcription of mRNA for the 2'5'-oligo(A) polymerase, which is subsequently translated upon removal of this inhibitor. In contrast, cells treated with type II interferon in the same way do not show increased levels of polymerase. This indicates that type II interferon cannot activate transcription of a stable mRNA for the polymerase when protein synthesis is inhibited. This observation and the different kinetics of induction of 2'5'-oligo(A) polymerase suggest major differences in the mechanism of action of the different types of interferon, with type I being a "direct" inducer of the polymerase and type II an "indirect" inducer. The commitment of HeLa cells to the induction of 2'5'-oligo(A) polymerase declines if the cells are exposed to type I interferon in the presence of an inhibitor of RNA synthesis. This suggests that transcription of specific mRNAs is transiently activated by interferon and that repeated interaction of interferon with its receptor may be required for prolonged transcription of the mRNA for 2'5'-oligo(A) polymerase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

Authors:  Y Shechter; L Preciado-Patt; G Schreiber; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Negative and positive regulation of human leukocyte antigen class I gene transcription in K562 leukemia cells.

Authors:  E Chen; R W Karr; G D Ginder
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

4.  Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.

Authors:  Y Karino; T Sugawara; A Saga; J Yoshida; T Matsushima; T Miyazaki; J Toyota; Y Okuuchi
Journal:  Gastroenterol Jpn       Date:  1989-04

5.  (2'-5') Oligoadenylate synthetase in the maturation of rabbit reticulocytes.

Authors:  D Ferbus; J Justesen; H Bertrand; M N Thang
Journal:  Mol Cell Biochem       Date:  1984-04       Impact factor: 3.396

6.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells.

Authors:  F H Sarkar; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

Authors:  M A Blanar; E C Boettger; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.

Authors:  J Higashihara; T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.